Skip to main content

Pharmacotherapeutics Across the Lifespan for APRNs (Advanced)

Tracking # 20-1374087

$15.00

4.5 (2 ratings)
Educator CEU'S FOR ALL
CE Broker Reporting Reported automatically
Method Computer-Based Training

What you'll learn

Upon completion of this course, the APRN student will demonstrate the ability to critically analyze pharmacotherapeutic interventions across diverse age groups, synthesize physiologic and developmental considerations into prescribing decisions, evaluate drug safety and efficacy in special populations, and apply evidence-based resources to optimize individualized care. Students will also demonstrate competency in managing polypharmacy, assessing teratogenic risk, and integrating pharmacogenomic data into clinical practice.

Course overview

This advanced pharmacotherapeutics course prepares APRNs to deliver highly specialized, evidence-based medication management across the lifespan, with emphasis on physiologic variability, developmental pharmacology, and population-specific risk stratification. The course integrates complex pharmacokinetic and pharmacodynamic principles with clinical decision-making, focusing on pediatric, geriatric, and perinatal populations. Students will critically evaluate drug therapies using authoritative resources such as the Physicians Desk Reference (PDR) and Facts & Comparisons, alongside primary literature and clinical guidelines, to optimize therapeutic outcomes while minimizing risk. Special attention is given to polypharmacy, pharmacogenomics, teratogenicity, and ethical prescribing considerations in vulnerable populations.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Midwife

4h Practice-Focused Continuing Education
4h Pharmacotherapeutics continuing education in the area of certification

Certified Nurse Practitioner

4h Practice-Focused Continuing Education
4h Pharmacotherapeutics continuing education in the area of certification

Certified Registered Nurse Anesthetist

4h Pharmacotherapeutics continuing education in the area of certification
4h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Certified Nurse Midwife

4h Pharmacology Component
4h Relevant to Clinical Nurse Midwife Specialty

Nurse Practitioner

4h Pharmacology Component
4h Relevant to Nurse Practitioner Specialty

Florida Board of Nursing

Advanced Practice Registered Nurse

4h Pharmacology for Autonomous Practice Initial Certification
4h General

Kansas State Board of Nursing

Nurse Midwife

4h Approved CNE Related to the Advanced Practice Registered Nurse

Nurse Practitioner

4h Approved CNE Related to the Advanced Practice Registered Nurse

Mississippi Board of Nursing

Certified Nurse Midwife

4h Prescribing Controlled Substances

Certified Registered Nurse Anesthetist

4h Prescribing Controlled Substances

Nurse Practitioner

4h Prescribing Controlled Substances

New Hampshire Board of Nursing

Advanced Practice Registered Nurse

4h Pharmacology
4h Specific to the Specialty Practice Area

New Mexico Board of Nursing

Certified Nurse Practitioner

4h Continuing education relevant to nursing practice
4h Continuing education related to pharmacology

Certified Registered Nurse Anesthetist

4h Continuing education related to pharmacology
4h Continuing education relevant to nursing practice

North Dakota Board of Nursing

Advanced Practice Registered Nurse

4h Pharmacotherapy Related to Scope of Practice

South Carolina Board of Nursing

Advanced Practice Registered Nurse

4h Pharmacotherapeutics

Tennessee Board of Nursing

Advanced Practice Registered Nurse

4h General

West Virginia Board of Registered Nurses

Advanced Practice Registered Nurse

4h Prescriptive Authority Privilege (RXA) pharmacotherapeutic

Wyoming Board of Nursing

Certified Nurse Midwife

4h CE related to the responsible prescribing of controlled substances or treatment of substance abuse disorders

Certified Nurse Practitioner

4h CE related to the responsible prescribing of controlled substances or treatment of substance abuse disorders

Disclosure statements

Course-Specific Verification Statements

This course meets advanced pharmacology requirements by addressing pharmacotherapeutic management in pediatric, adult, geriatric, and perinatal populations. It emphasizes physiologic variability, developmental pharmacology, and population-specific risk factors. The course aligns with NONPF competencies related to patient-centered care and population health, and incorporates evidence from authoritative sources to guide safe prescribing across diverse populations. The use of the PDR and Facts & Comparisons ensures accurate dosing and safety considerations in vulnerable groups.

 

References

  • National Organization of Nurse Practitioner Faculties. Nurse Practitioner Core Competencies
  • American Association of Nurse Practitioners (AANP). Scope of Practice and Certification Standards
  • American Nurses Credentialing Center. APRN Certification Requirements
  • AACN Essentials. The Essentials of Graduate Nursing Education
  • Centers for Disease Control and Prevention. Clinical Practice Guidelines
  • U.S. Drug Enforcement Administration. Controlled Substances Act and Prescribing Regulations
  • Institute for Healthcare Improvement. Patient Safety and Quality Standards
  • Brunton, L.L. et al. Goodman & Gilman’s The Pharmacological Basis of Therapeutics
  • Katzung, B.G. Basic & Clinical Pharmacology
  • Arcangelo, V., & Peterson, A. Pharmacotherapeutics for Advanced Practice
  • Physicians’ Desk Reference (PDR), latest edition
  • Facts & Comparisons eAnswers Drug Reference


Method of Evaluation:

Participant achievement of the stated learning objectives is evaluated through completion of a post-test examination and review of case-based scenarios. A minimum passing score of 70% is required for successful completion. 

 

Learner Feedback